Medical Xpress on MSN15d
Pioneering research identifies three subtypes of osteosarcoma for better treatment
The survival rate for osteosarcoma, a type of bone cancer, has stagnated around 50pc for the past 45 years. This is mainly because the different subtypes of osteosarcoma are not yet fully understood, ...
Pharmaceutical Technology4d
OMO-103 by Peptomyc for Osteosarcoma: Likelihood of Approval
OMO-103 is under development for the treatment of metastatic pancreatic ductal adenocarcinoma (PDAC), advanced high-grade osteosarcoma and metastatic pancreatic cancer. The therapeutic candidate is a ...
Medscape5d
Novel Therapeutic Agents for Osteosarcoma
Survival for patients with metastatic or relapsed osteosarcoma is poor. Survival for patients with osteosarcoma has remained unchanged for the past 15-20 years. Improving outcome for patients with ...
Cedar Rapids KCRG-TV on MSN12d
After losing daughter to cancer, Coralville mother pushes for more research
CORALVILLE, Iowa (KCRG) - A Coralville mother is hoping to use her family’s tragedy to raise awareness for cancer research ...
devdiscourse15d
Breakthrough in Osteosarcoma Research Unearths Subtypes for Targeted Treatment
Researchers have identified three distinct subtypes of osteosarcoma, a rare bone cancer, using advanced mathematical modeling ...